Navigation Links
UNC receives record $181 million grant to evaluate health, poverty and gender programs worldwide
Date:9/8/2008

The United States Agency for International Development (USAID) has awarded the Carolina Population Center at the University of North Carolina at Chapel Hill up to $181 million to continue its MEASURE Evaluation project.

The award is the largest ever received by UNC.

The award funds the monitoring and evaluation of family planning, maternal and child health, nutrition and HIV/AIDS programs around the world. The project also monitors and evaluates malaria, tuberculosis and avian influenza programs, and will expand to programs addressing poverty and gender equity.

Going into its third phase, MEASURE Evaluation builds on the previous two phases of the project and the earlier EVALUATION project which began in 1991. The project already has a presence in nearly 50 countries in Africa, Asia, Europe and Latin America and will expand to more. Besides the $181 million of project funding in this grant, the award includes the potential for countries to request evaluation activities valued at up to an additional $125 million over the five years.

"The size of this award is unprecedented," said Barbara Entwisle, Ph.D., director of the Carolina Population Center (CPC) and Kenan Professor of Sociology in the UNC College of Arts and Sciences. "Faculty at UNC, specifically those at the Carolina Population Center who are part of the MEASURE Evaluation team, have achieved an international reputation for excellence in evaluation research.

The funding of this latest stage of the project acknowledges the great success of the MEASURE Evaluation team in its earlier phases."

Sian Curtis, Ph.D., research associate professor of maternal and child health in the School of Public Health and a CPC fellow, is principal investigator and project director. Gustavo Angeles, Ph.D., assistant professor of maternal and child health in the School of Public Health and CPC fellow, is co-principal investigator and deputy director.

"Good information is essential to improve the health of the world's population," Curtis said. "This award provides a fabulous opportunity to strengthen our understanding of global health programs and improve the collection, analysis and use of population and health information."

The project's partners includes John Snow Inc., Macro International, Tulane University, The Futures Group International and Management Sciences for Health.

The MEASURE (Monitoring and Evaluation to Assess and Use Results) Evaluation project uses different strategies to collect and use data about health issues. For example, a tool for assessing and modifying HIV/AIDS prevention programs locally or nationally called the Priorities for Local AIDS Efforts (PLACE) method can identify geographic areas that contain key HIV transmission networks. The PLACE method was developed by Sharon Weir, Ph.D., research assistant professor of epidemiology in the School of Public Health and a CPC fellow.

The project will focus on developing the expertise of health workers and officials in host countries to collect, analyze and use data that are gathered. Building on its existing monitoring and evaluation training courses, researchers will launch a distance learning component to increase the number of people who are trained to monitor and evaluate health programs. Communities of practice will also be created so people from different countries who work on the same health issue can share information and learn from each other.


'/>"/>

Contact: Patric Lane
patric_lane@unc.edu
919-962-8596
University of North Carolina at Chapel Hill
Source:Eurekalert

Related medicine news :

1. Arthrosurface HemiCAP(R) Focal Knee Resurfacing Implant Receives FDA Approval to Move into Final Investigational Stage
2. College of American Pathologists' Education Division Receives Top Honor
3. CMS, Inc., an Elekta Company, Receives FDA 510(k) Clearance for Atlas-Based Autosegmentation Software
4. Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder
5. Actavis Receives Approval of Generic Wellbutrin XL(R) 300mg in the U.S.
6. New probe to detect skin cancer receives more funding for clinical trials
7. NUCRYST Receives Deficiency Notice from NASDAQ
8. Dr. Ajrawats Air-Pulse Autonomic Meditation Therapy, a Revolutionary, Scientific, Meditation Therapy, Receives Patent Trademark
9. PathNet Esoteric Laboratory Institute Main Laboratory Receives Accreditation From College of American Pathologists
10. Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis
11. Morris Animal Foundation Receives $1 Million Donation From Hills for Cat Health Research - Cat Lovers Have Reason to Celebrate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... , ... May 03, 2016 , ... ... announced that it has been honored as one of the nation’s most accomplished ... InformationWeek Elite 100. Horizon received the recognition for technology achievements that have enabled ...
(Date:5/3/2016)... ... May 03, 2016 , ... BioPlus Specialty Pharmacy ... at the 2016 Asembia Specialty Pharmacy Summit held May 2-6, 2016 at the ... health care conference for the specialty pharmacy industry, with thousands of pharmacy providers, ...
(Date:5/3/2016)... ... May 03, 2016 , ... Empyrean Benefit Solutions, Inc., the ... service center in La Vergne, Tennessee, near Nashville. The new center will complement ... Empyrean client services. , “Our Nashville-area center allows us to achieve several goals,” ...
(Date:5/3/2016)... (PRWEB) , ... May 03, 2016 , ... Park Cities ... live in or adjacent to the 75204, 75205, 75206, 75209, 75219, 75220, 75225, 75229, ... Greenway Parks, Bluffview, Midway Hollow, North Dallas, Plano, Preston Hollow and Park Cities areas ...
(Date:5/3/2016)... , ... May 03, 2016 , ... ... one of Canada’s top Information and Communication Technology (ICT) companies in the annual ... Multinational ICT companies operating in Canada, as ranked by revenue. , “We ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... LAWRENCEVILLE, N.J. , May 2, 2016 /PRNewswire/ ... drug development company, today announced data from the ... dose escalating clinical trial (the OVATION Study) combining ... of care for the treatment of newly-diagnosed patients ... chemotherapy followed by interval debulking surgery.  In the ...
(Date:4/29/2016)... , April 29, 2016 ... H1 2016" market research report that provides an ... comparative analysis at various stages, therapeutics assessment by ... administration (RoA) and molecule type, along with latest ... also reviews key players involved in the therapeutic ...
(Date:4/29/2016)... Glycotope GmbH, a clinical-stage immuno-oncology ... appointment of Dr. Alfredo Zurlo as Chief ... with many years clinical experience and a proven track ... role was at Mologen AG where he was Chief ... Dr. Zurlo held various positions at F Hoffmann La ...
Breaking Medicine Technology: